Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

CD56+ T cells inhibit hepatitis C virus replication in human hepatocytes.

Ye L, Wang X, Wang S, Wang Y, Song L, Hou W, Zhou L, Li H, Ho W.

Hepatology. 2009 Mar;49(3):753-62. doi: 10.1002/hep.22715.

2.

Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes.

Wang Y, Ye L, Wang X, Li J, Song L, Ho W.

Innate Immun. 2013;19(2):193-202. doi: 10.1177/1753425912460414. Epub 2012 Oct 11.

3.

CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of hepatitis C virus-infected cells and induction of interferon-alpha.

Zhang S, Kodys K, Babcock GJ, Szabo G.

Hepatology. 2013 Sep;58(3):940-9. doi: 10.1002/hep.25827. Epub 2013 Jan 18.

4.

ISG12a inhibits HCV replication and potentiates the anti-HCV activity of IFN-α through activation of the Jak/STAT signaling pathway independent of autophagy and apoptosis.

Chen Y, Jiao B, Yao M, Shi X, Zheng Z, Li S, Chen L.

Virus Res. 2017 Jan 2;227:231-239. doi: 10.1016/j.virusres.2016.10.013. Epub 2016 Oct 21.

PMID:
27777077
5.

CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway.

Rau SJ, Hildt E, Himmelsbach K, Thimme R, Wakita T, Blum HE, Fischer R.

Hepatology. 2013 Jan;57(1):23-36. doi: 10.1002/hep.25966.

PMID:
22814930
6.

Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Mukherjee A, Di Bisceglie AM, Ray RB.

J Virol. 2015 Mar;89(6):3356-65. doi: 10.1128/JVI.03085-14. Epub 2015 Jan 14.

7.

Alcohol impairs interferon signaling and enhances full cycle hepatitis C virus JFH-1 infection of human hepatocytes.

Ye L, Wang S, Wang X, Zhou Y, Li J, Persidsky Y, Ho W.

Drug Alcohol Depend. 2010 Nov 1;112(1-2):107-16. doi: 10.1016/j.drugalcdep.2010.05.008. Epub 2010 Jun 20.

8.

Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes.

Wang Y, Li J, Wang X, Ye L, Zhou Y, Ho W.

J Viral Hepat. 2013 Jun;20(6):385-94. doi: 10.1111/jvh.12040. Epub 2013 Jan 7.

9.

Natural killer cells inhibit hepatitis C virus expression.

Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ.

J Leukoc Biol. 2004 Dec;76(6):1171-9. Epub 2004 Aug 31.

PMID:
15339939
10.

Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.

Nandakumar R, Finsterbusch K, Lipps C, Neumann B, Grashoff M, Nair S, Hochnadel I, Lienenklaus S, Wappler I, Steinmann E, Hauser H, Pietschmann T, Kröger A.

Gastroenterology. 2013 Dec;145(6):1414-23.e1. doi: 10.1053/j.gastro.2013.08.037. Epub 2013 Aug 21.

PMID:
23973921
11.

Upregulation of SOCS-3 and PIAS-3 impairs IL-12-mediated interferon-gamma response in CD56 T cells in HCV-infected heroin users.

Ye L, Wang X, Metzger DS, Riedel E, Montaner LJ, Ho W.

PLoS One. 2010 Mar 9;5(3):e9602. doi: 10.1371/journal.pone.0009602.

12.

Natural killer cells suppress full cycle HCV infection of human hepatocytes.

Wang SH, Huang CX, Ye L, Wang X, Song L, Wang YJ, Liang H, Huang XY, Ho WZ.

J Viral Hepat. 2008 Dec;15(12):855-64. doi: 10.1111/j.1365-2893.2008.01014.x. Epub 2008 Jul 10.

13.

Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes.

Stevenson NJ, Bourke NM, Ryan EJ, Binder M, Fanning L, Johnston JA, Hegarty JE, Long A, O'Farrelly C.

FEBS Lett. 2013 May 21;587(10):1571-8. doi: 10.1016/j.febslet.2013.03.041. Epub 2013 Apr 12.

14.

Cyclosporin A inhibits hepatitis C virus replication and restores interferon-alpha expression in hepatocytes.

Liu JP, Ye L, Wang X, Li JL, Ho WZ.

Transpl Infect Dis. 2011 Feb;13(1):24-32. doi: 10.1111/j.1399-3062.2010.00556.x. Epub 2010 Oct 7.

15.

CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.

Kokordelis P, Krämer B, Boesecke C, Voigt E, Ingiliz P, Glässner A, Wolter F, Srassburg CP, Spengler U, Rockstroh JK, Nattermann J.

J Acquir Immune Defic Syndr. 2015 Dec 1;70(4):338-46. doi: 10.1097/QAI.0000000000000793.

PMID:
26509931
16.

Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.

Plumlee CR, Lazaro CA, Fausto N, Polyak SJ.

Virol J. 2005 Dec 2;2:89.

17.

Hepatitis C virus replication in transfected and serum-infected cultured human fetal hepatocytes.

Lázaro CA, Chang M, Tang W, Campbell J, Sullivan DG, Gretch DR, Corey L, Coombs RW, Fausto N.

Am J Pathol. 2007 Feb;170(2):478-89.

18.

Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.

Hazari S, Chandra PK, Poat B, Datta S, Garry RF, Foster TP, Kousoulas G, Wakita T, Dash S.

Virol J. 2010 Feb 11;7:36. doi: 10.1186/1743-422X-7-36.

19.

Use of laser capture microdissection to map hepatitis C virus-positive hepatocytes in human liver.

Kandathil AJ, Graw F, Quinn J, Hwang HS, Torbenson M, Perelson AS, Ray SC, Thomas DL, Ribeiro RM, Balagopal A.

Gastroenterology. 2013 Dec;145(6):1404-13.e1-10. doi: 10.1053/j.gastro.2013.08.034. Epub 2013 Aug 22.

20.

Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.

Kurt R, Chandra PK, Aboulnasr F, Panigrahi R, Ferraris P, Aydin Y, Reiss K, Wu T, Balart LA, Dash S.

PLoS One. 2015 May 11;10(5):e0125962. doi: 10.1371/journal.pone.0125962. eCollection 2015.

Supplemental Content

Support Center